Rivaroxaban in prevention of stroke in elderly patients with non-valvular atrial fibrillation | Zendy

I. S. Yavelov | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rivaroxaban in prevention of stroke in elderly patients with non-valvular atrial fibrillation

Author(s) -

I. S. Yavelov

Publication year - 2020

Publication title -

kardiologiia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.159

H-Index - 16

eISSN - 2412-5660

pISSN - 0022-9040

DOI - 10.18087/cardio.n892

Subject(s) - rivaroxaban , atrial fibrillation , medicine , warfarin , stroke (engine) , cardiology , randomized controlled trial , mechanical engineering , engineering

Data regarding efficacy and safety of direct oral anticoagulant rivaroxaban in prevention of stroke in elderly polymorbid patients with non-valvular atrial fibrillation are presented. In this aspect results of randomized clinical trial in direct comparison of rivaroxaban and warfarin in patients with non-valvular atrial fibrillation ROCKET-AF are discussed. Results of rivaroxaban use in elderly patients in real medical practice are also considered.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research